Qijing Wang

714 total citations
11 papers, 217 citations indexed

About

Qijing Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Qijing Wang has authored 11 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Qijing Wang's work include Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer-related Molecular Pathways (2 papers). Qijing Wang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer-related Molecular Pathways (2 papers). Qijing Wang collaborates with scholars based in China. Qijing Wang's co-authors include Desheng Weng, Qiuzhong Pan, Yongqiang Li, Tong Xiang, Jian‐Chuan Xia, Jingjing Zhao, Mengjia Song, Jieying Yang, Ke Pan and Yulong Han and has published in prestigious journals such as Oncogene, The FASEB Journal and Frontiers in Immunology.

In The Last Decade

Qijing Wang

11 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qijing Wang China 10 140 70 56 53 29 11 217
Chaoyi Yuan China 7 138 1.0× 69 1.0× 38 0.7× 63 1.2× 47 1.6× 12 247
Francesca Pia Caruso Italy 10 155 1.1× 101 1.4× 72 1.3× 90 1.7× 38 1.3× 19 281
Reham Helwa Egypt 9 210 1.5× 75 1.1× 48 0.9× 99 1.9× 49 1.7× 19 322
Jiangzheng Zeng China 9 98 0.7× 47 0.7× 30 0.5× 71 1.3× 35 1.2× 20 194
Gaurav Sharma United States 7 127 0.9× 91 1.3× 35 0.6× 52 1.0× 31 1.1× 18 257
Xue Zheng China 5 122 0.9× 63 0.9× 30 0.5× 55 1.0× 29 1.0× 9 191
Darlan Conterno Minussi United States 8 119 0.8× 55 0.8× 45 0.8× 120 2.3× 16 0.6× 11 223
Huiyun Cai China 8 127 0.9× 110 1.6× 56 1.0× 81 1.5× 31 1.1× 16 279
Ruoyang Shao China 6 96 0.7× 53 0.8× 77 1.4× 27 0.5× 14 0.5× 13 206
Soren Charmsaz United States 8 73 0.5× 103 1.5× 61 1.1× 40 0.8× 24 0.8× 15 184

Countries citing papers authored by Qijing Wang

Since Specialization
Citations

This map shows the geographic impact of Qijing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qijing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qijing Wang more than expected).

Fields of papers citing papers by Qijing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qijing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qijing Wang. The network helps show where Qijing Wang may publish in the future.

Co-authorship network of co-authors of Qijing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qijing Wang. A scholar is included among the top collaborators of Qijing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qijing Wang. Qijing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Yuanyuan, Yan Tang, Jingjing Zhao, et al.. (2024). Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene. 43(28). 2143–2159. 5 indexed citations
2.
Yuan, Hang, Gang Zhao, Qin Li, et al.. (2023). Ultrasensitive detection of circulating tumor cells in clinical blood samples by a three-dimensional network nanovehicle-based aptasensor platform. Sensors and Actuators B Chemical. 404. 135172–135172. 12 indexed citations
3.
Song, Mengjia, Jieying Yang, Qiuzhong Pan, et al.. (2023). Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer. Theranostics. 13(5). 1649–1668. 12 indexed citations
4.
Yang, Jieying, Zhixing Guo, Mengjia Song, et al.. (2023). Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma. Frontiers in Immunology. 14. 1212577–1212577. 13 indexed citations
5.
Li, Qin, Hang Yuan, Gang Zhao, et al.. (2023). ZNF32 prevents the activation of cancer‐associated fibroblasts through negative regulation of TGFB1 transcription in breast cancer. The FASEB Journal. 37(4). e22837–e22837. 10 indexed citations
6.
Huang, Yue, Jieying Yang, Qiuzhong Pan, et al.. (2022). CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma. Cell Death and Disease. 13(3). 251–251. 35 indexed citations
7.
Yang, Jieying, Mengjia Song, Qiuzhong Pan, et al.. (2022). SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway. International Journal of Biological Sciences. 18(14). 5241–5259. 23 indexed citations
8.
Miao, Jingjing, Qiuzhong Pan, Zonglong Wu, et al.. (2022). OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis. Journal of Experimental & Clinical Cancer Research. 41(1). 328–328. 50 indexed citations
9.
Pan, Qiuzhong, Jingjing Zhao, Yan Tang, et al.. (2020). Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer. Clinical & Translational Immunology. 9(2). e1113–e1113. 11 indexed citations
10.
Pan, Qiuzhong, Ke Pan, Desheng Weng, et al.. (2015). Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma. Molecular Carcinogenesis. 55(1). 64–76. 23 indexed citations
11.
Ma, Haiqing, Desheng Weng, Yibing Chen, et al.. (2010). Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Molecular Cancer. 9(1). 190–190. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026